Kokilakshadi vati will be useful in management of Cholelithiasis

Comparative Evaluation of Efficacy of Kokilakshadi vati versus Tab Ursodiol in the management of Pittashmari (Cholelithiasis). - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073917

Enrollment

Registered

2024-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K808- Other cholelithiasis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with clinical features of Cholelithiasis. viz. pain in upper right quadrant of the abdomen, referring pain to the inferior angle of right scapula, vomiting, nausea, flatulent dyspepsia Asymptomatic patients who are diagnosed to have Cholelithiasis accidentally by USG abdomen or X-ray. Patients of either sex with multiple stones which are 4mm -20mm.

Exclusion criteria

Exclusion criteria: Patients suffering from other systemic disorders and condition which interfere with the treatment and requiring surgical intervention will be excluded. Patients with gall stones associated with complications, such as acute cholecystitis, acute pancreatitis, liver failure, carcinoma of gall bladder and any other pathological condition Stones present in cystic duct and common bile duct presenting with the sign jaundice. Immune compromised patients.

Design outcomes

Primary

Measure	Time frame
To remove the gall bladder stone .Timepoint: 60 days	—

Secondary

Measure	Time frame
To relive the pain and reduce the size of stone.Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Krishna Subhashrao Shinde

Datta Meghe Institute of Higher Education And Research

devyani.dasar@dmiher.edu.in9503630392

Outcome results